Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma... Read More
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The... Read More
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent... Read More
BeiGene, a biotechnology company, has taken legal action by filing patent infringement lawsuits against pharmaceutical companies Sandoz and MSN Pharmaceuticals,... Read More
Written by: Paige L. Cappelli The inaugural AAMI/FDA neXus medical device standards conference was held February 20-23, 2024 in Washington DC.... Read More